Results 181 to 190 of about 2,712 (224)
Some of the next articles are maybe not open access.

SAT-391 Switching from zinc salts to Trientine Tetrahydrochloride in Wilson disease: the ZICUP study

Journal of Hepatology
D. Debray   +6 more
semanticscholar   +1 more source

Long-term outcomes on Quality of Life in patients with Wilson disease treated with Trientine dihydrochloride

Viszeralmedizin 2023 77. Jahrestagung der DGVS mit Sektion Endoskopie Herbsttagung der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie mit den Arbeitsgemeinschaften der DGAV und Jahrestagung der CACP, 2023
I. Mohr   +3 more
semanticscholar   +1 more source

Multicentre, retrospective study to assess long-term outcomes of chelator based treatment with trientine in Wilson disease patients withdrawn from therapy with d-penicillamine

European Journal of Gastroenterology and Hepathology, 2022
K. Weiss   +8 more
semanticscholar   +1 more source

SAT-388 Integrated PK-PD model relating serum copper concentrations, urinary copper clearance and trientine pharmacokinetics in Wilson disease: initial insights from the UNITED study

Journal of Hepatology
Peter Vis   +14 more
semanticscholar   +1 more source

Results of the up-titration phase of the UNITED study, an open label, multicenter, prospective study to characterize the pharmacokinetics and pharmacodynamics of trientine dihydrochloride and to investigate the efficacy and safety in Wilson disease patients

Zeitschrift für Gastroenterologie - German Journal of Gastroenterology
I. Mohr   +12 more
semanticscholar   +1 more source

Trientine-Induced Enteritis in Wilson Disease Treatment.

Journal of Hepatology
Rachel Orbuch, Amanda Cheung
semanticscholar   +1 more source

The copper-chelating agent, trientine, suppresses tumor development and angiogenesis in the murine hepatocellular carcinoma cells

International Journal of Cancer, 2001
Hitoshi Yoshiji   +2 more
exaly  

Home - About - Disclaimer - Privacy